mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |